Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 16, 2011 13:33 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Reports Second Quarter FY2012 Financial Results

MORRISVILLE, N.C., Dec. 16, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX:OXBT), a development stage biomedical company focused on developing oxygen-rich intravenous and...
December 09, 2011 08:35 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Announces Registered Financing for up to $7.5 Million in Gross Proceeds

MORRISVILLE, N.C., Dec. 9, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX:OXBT) today announced that it has entered into definitive agreements with institutional investors...
November 22, 2011 11:20 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics to Present at 23rd Annual Piper Jaffray Healthcare Conference

MORRISVILLE, N.C., Nov. 22, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX:OXBT) today announced that Chief Financial Officer and Interim CEO Michael Jebsen will present at...
October 27, 2011 16:45 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics to Voluntarily Withdraw Secondary Listing From SIX Swiss Stock Exchange

MORRISVILLE, N.C., Oct. 27, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX:OXBT) today announced that the SIX Swiss Stock Exchange has approved the application filed by the...
September 30, 2011 17:59 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Names Dr. Ronald Blanck Chairman of the Board

MORRISVILLE, N.C., Sept. 30, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced that Ronald R. Blanck, DO, was appointed Chairman of the...
September 19, 2011 17:25 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Reports First Quarter FY2012 Financial Results and Announces Conference Call and Webcast for Shareholders

MORRISVILLE, N.C., Sept. 19, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT), a development stage biomedical company focused on developing oxygen-rich...
August 24, 2011 17:15 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics Announces Dismissal of Chris J. Stern as CEO and Appointments of Michael B. Jebsen as Interim CEO and Rene Eckert as Interim Chairman

MORRISVILLE, N.C., Aug. 24, 2011 (GLOBE NEWSWIRE) -- The Board of Directors of Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) today announced that Chris J. Stern is no longer...
August 01, 2011 09:00 ET | Source: Tenax Therapeutics, Inc.

Photo Release -- Beat the Summertime Skin Blues With Dermacyte(R) Summer Rescue Bundle to Soothe Dry Skin and Bring Back a Youthful Glow

MORRISVILLE, N.C., Aug. 1, 2011 (GLOBE NEWSWIRE) -- Let's face it: summer is fun, but it can be tough on your skin. Most of us spend more hours outdoors in summer than during any other season doing...
July 25, 2011 02:00 ET | Source: Tenax Therapeutics, Inc.

Oxygen Biotherapeutics and Aurum Biosciences Sign Letter of Intent to Explore the Use of Oxycyte(R) PFC for Imaging and Therapeutic Intervention of Acute Ischemic Stroke

MORRISVILLE, N.C., July 25, 2011 (GLOBE NEWSWIRE) -- Oxygen Biotherapeutics, Inc. (Nasdaq:OXBT) (SIX Swiss Exchange:OXBT) and privately held Aurum Biosciences, Ltd. of Glasgow, Scotland, today...
July 20, 2011 08:00 ET | Source: Tenax Therapeutics, Inc.

Global Interest in the Potential Medical Benefits of Novel Perfluorocarbon At All Time High

MORRISVILLE, N.C., July 20, 2011 (GLOBE NEWSWIRE) -- University and educational institution researchers from the United Kingdom, Switzerland and the United States all have one thing in common: an...